Mazdutide was named among the Top 10 Most Anticipated Drug Launches of 2025 by FIERCE Pharma, and its Phase 2 clinical trial was selected by Nature Communications as one of the 50 most important studies in translational and clinical research
10.1073/pnas.1821332116 44 FiebichB
Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus
American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 168, 151161.CrossRefGoogle Scholar Heppner, KM, Kirigiti, M, Secher, A, Paulsen, SJ, Buckingham, R, Pyke, C, Knudsen, LB, Vrang, N and Grove, KL (2015) Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain
Final Thoughts At Supplements Made Simple, our aim is to help make supplements feel less confusing and more approachable, with science-backed products designed to fit into real life
Discovery of the once-weekly Glucagon-Like Peptide-1 (GLP-1) analogue semaglutide